We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

74 hedge funds and large institutions have $365M invested in ProQR Therapeutics in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 24 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 9

10% more funds holding

Funds holding: 67 → 74 (+7)

9% more capital invested

Capital invested by funds: $333M → $365M (+$31.4M)

8.76% more ownership

Funds ownership: 62.19% → 70.95% (+8.8%)

4% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 24

17% less call options, than puts

Call options by funds: $485K | Put options by funds: $584K

Holders
74
Holders Change
+7
Holders Change %
+10.45%
% of All Funds
1.14%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
18
Increased
25
Reduced
24
Closed
9
Calls
$485K
Puts
$584K
Net Calls
-$99K
Net Calls Change
-$925K

Top Buyers

Rank Fund Capital Flow
1
CAC
Cowen and Company
New York
+$9.89M
2
GPP
Great Point Partners
Connecticut
+$8.31M
3
RI
RTW Investments
New York
+$4.45M
4
Goldman Sachs
Goldman Sachs
New York
+$3.67M
5
BlackRock
BlackRock
New York
+$3.3M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$10.2M
2
KA
Kerrisdale Advisers
Florida
-$3.33M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.52M
4
JP Morgan Chase
JP Morgan Chase
New York
-$1.84M
5
DCM
DAFNA Capital Management
California
-$1.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
RI
1
RTW Investments
New York
$56.3M +$4.45M +584,612 +9%
PFM
2
Privium Fund Management
Netherlands
$38.9M +$36.3M +4,765,659 New
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$37.8M – – –
Fidelity Investments
4
Fidelity Investments
Massachusetts
$35.7M -$2.52M -330,835 -7%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$32.2M -$10.2M -1,334,085 -25%
Goldman Sachs
6
Goldman Sachs
New York
$31.3M +$3.67M +481,325 +14%
DCM
7
Driehaus Capital Management
Illinois
$16M -$640K -83,996 -4%
Jennison Associates
8
Jennison Associates
New York
$14.5M -$207K -27,248 -1%
CAC
9
Cowen and Company
New York
$12.5M +$9.89M +1,298,183 +487%
OM
10
Opaleye Management
Massachusetts
$11.5M +$86.1K +11,310 +0.8%
GGHC
11
Gilder Gagnon Howe & Co
New York
$11M +$1.72M +226,211 +20%
GPP
12
Great Point Partners
Connecticut
$8.98M +$8.31M +1,090,786 +3,596%
Fidelity International
13
Fidelity International
Bermuda
$8.2M -$1.39M -181,935 -15%
JP Morgan Chase
14
JP Morgan Chase
New York
$5.68M -$1.84M -241,581 -25%
Macquarie Group
15
Macquarie Group
Australia
$4.97M – – –
Deutsche Bank
16
Deutsche Bank
Germany
$4.06M -$565K -74,184 -13%
BlackRock
17
BlackRock
New York
$3.91M +$3.3M +433,485 +796%
Point72 Asset Management
18
Point72 Asset Management
Connecticut
$3.69M +$23.6K +3,100 +0.7%
PM
19
Prosight Management
Texas
$2.86M +$566K +74,361 +26%
Rafferty Asset Management
20
Rafferty Asset Management
New York
$2.74M -$1.43M -187,800 -35%
AGA
21
Altrinsic Global Advisors
Connecticut
$2.57M – – –
Millennium Management
22
Millennium Management
New York
$2.04M -$632K -83,035 -25%
Citadel Advisors
23
Citadel Advisors
Florida
$1.78M +$990K +130,063 +141%
State Street
24
State Street
Massachusetts
$1.53M +$708K +92,914 +95%
Bank of America
25
Bank of America
North Carolina
$1.51M +$865K +113,558 +153%
1
2 3 4

PRQR Hedge Fund Activity: Q4 2021 in Review

74 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q4 2021, worth a combined $365M — up 9.4% from $333M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new PRQR positions and 9 closed out — a net gain of 9 holders — while 25 added to existing stakes and 24 trimmed.

The largest buyer was Cowen and Company, adding an estimated $9.89M. The largest seller was Wellington Management Group, cutting an estimated $10.2M.

  • 74 institutional investors held ProQR Therapeutics (PRQR) as of Q4 2021, up from 67 in Q3 2021.
  • Funds reported $365M of ProQR Therapeutics stock for Q4 2021, up 9.4% quarter-over-quarter.
  • 18 funds opened new ProQR Therapeutics positions in Q4 2021 and 9 closed out, a net change of +9 holders.
  • The largest ProQR Therapeutics buyer in Q4 2021 was Cowen and Company, an estimated $9.89M added.
  • The largest ProQR Therapeutics seller in Q4 2021 was Wellington Management Group, an estimated $10.2M sold.

Based on aggregated 13F filings for Q4 2021.